Bacteriophages and their use in combating antimicrobial resistance

  21 February 2025

Bacteriophages, natural viruses that selectively target and kill bacteria, are crucial in regulating bacterial populations and influencing microbial ecosystems. Phages can destroy bacteria resistant to drugs like antibiotics, and their therapy could be a promising tool for controlling antimicrobial resistance (AMR), a global public health and development threat. AMR is responsible for 133,000 deaths annually in the European Region and costs €11.7 billion annually. Phages offer biologically innovative approaches to AMR, ranging from therapeutic use in humans and animals to potentially replacing antibiotic use in agriculture.

Further reading: WHO
Author(s): WHO
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed